NIH-funded research Fellowship grant

Investigating how GLP1R agonists help regulate weight through brain pathways

Official title: Weight Regulation by GLP1R agonists via a non-canonical hypothalamic PKA-mTORC1 mediated pathway

Funded at Vanderbilt University · NIH-11162944 · Data updated 2026-11-12

This study is looking at how a new type of weight loss medication called GLP1R agonists works in the brain to help people lose weight by affecting appetite, and it aims to find out how these drugs can lead to better treatments for obesity.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionVanderbilt University
NIH-funded
Lab location1 site (Nashville, UNITED STATES)
Project startMay 1, 2025
Project endApril 30, 2028
Funding year2025
Award (this year)$34,370
NIH project number1F31DK141243-01A1
Project IDNIH-11162944 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals aged 21 and older who are struggling with obesity and may benefit from new weight-loss medications.

Less likely to help

Patients who are not overweight or do not have obesity-related conditions may not receive any benefit from this research.

What this research studies

This research explores how GLP1R agonists, a new class of drugs for obesity treatment, work in the brain to promote weight loss. It focuses on understanding the molecular mechanisms involved, particularly how these drugs activate a specific protein complex that influences appetite regulation. By studying certain neurons in the hypothalamus, the research aims to uncover the pathways that lead to reduced body weight when using GLP1R agonists. This could provide insights into more effective obesity treatments.

Why it matters

Potential benefit: If successful, this research could lead to improved obesity treatments that effectively regulate weight through targeted brain pathways.

How similar studies have gone: Previous research has shown promising results with GLP1R agonists in weight management, indicating that this approach has potential for success.

Where this research is happening

  • Vanderbilt University
    Nashville, United States
    Active

Researchers

  • Principal investigator: Raghavan, Ritika — Vanderbilt University
  • Study coordinator: Raghavan, Ritika

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.